Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

2.

Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, Cassard SD, Hollis BW, Crainiceanu C, Mowry EM.

Mult Scler. 2016 May;22(6):753-60. doi: 10.1177/1352458515600248.

PMID:
26286698
3.

Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.

Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE.

Nutr J. 2015 Aug 18;14:81. doi: 10.1186/s12937-015-0072-6.

4.

Success of Standard Dose Vitamin D Supplementation in Treated Human Immunodeficiency Virus Infection.

Lake JE, Hoffman RM, Tseng CH, Wilhalme HM, Adams JS, Currier JS.

Open Forum Infect Dis. 2015 May 15;2(2):ofv068. doi: 10.1093/ofid/ofv068.

5.

Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Pierrot-Deseilligny C, Souberbielle JC.

Ther Adv Neurol Disord. 2013 Mar;6(2):81-116. doi: 10.1177/1756285612473513.

6.

The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.

Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA.

Ann Surg Oncol. 2012 Aug;19(8):2590-9. doi: 10.1245/s10434-012-2297-3.

7.

Vitamin D in HIV-Infected Patients.

Lake JE, Adams JS.

Curr HIV/AIDS Rep. 2011 Sep;8(3):133-41. doi: 10.1007/s11904-011-0082-8. Review.

8.

The effect of various vitamin D supplementation regimens in breast cancer patients.

Peppone LJ, Huston AJ, Reid ME, Rosier RN, Zakharia Y, Trump DL, Mustian KM, Janelsins MC, Purnell JQ, Morrow GR.

Breast Cancer Res Treat. 2011 May;127(1):171-7. doi: 10.1007/s10549-011-1415-4.

9.

Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Kriegel MA, Manson JE, Costenbader KH.

Semin Arthritis Rheum. 2011 Jun;40(6):512-531.e8. doi: 10.1016/j.semarthrit.2010.07.009. Review.

10.

Complementary and alternative medicine for the treatment of multiple sclerosis.

Yadav V, Shinto L, Bourdette D.

Expert Rev Clin Immunol. 2010 May;6(3):381-95. doi: 10.1586/eci.10.12.

11.

Benefit-risk assessment of vitamin D supplementation.

Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC.

Osteoporos Int. 2010 Jul;21(7):1121-32. doi: 10.1007/s00198-009-1119-3. Review.

Supplemental Content

Support Center